- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x JUQ: (1~{S},2~{S})-2-[5-[cyclopropylmethyl(naphthalen-1-yl)amino]-4-methoxy-pyrimidin-2-yl]carbonylcyclopropane-1-carboxylic acid(Non-covalent)
- 1 x NI: NICKEL (II) ION(Non-covalent)
- 11 x PLM: PALMITIC ACID(Non-covalent)
PLM.3: 3 residues within 4Å:- Chain A: P.139, L.142, R.143
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:L.142
PLM.4: 2 residues within 4Å:- Chain A: L.134, F.137
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.134, A:F.137, A:F.137
PLM.5: 9 residues within 4Å:- Chain A: H.8, E.11, W.75, I.79
- Chain C: H.7, L.71, W.75
- Ligands: PLM.6, PLM.10
8 PLIP interactions:4 interactions with chain C, 4 interactions with chain A- Hydrophobic interactions: C:L.71, C:W.75, C:W.75, A:H.8, A:W.75, A:W.75, A:I.79
- Salt bridges: C:H.7
PLM.6: 9 residues within 4Å:- Chain A: H.7, H.8, L.71, W.75
- Chain B: E.11, W.75, I.79
- Ligands: PLM.5, PLM.10
6 PLIP interactions:4 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:L.71, A:W.75, A:W.75, B:W.75, B:I.79
- Hydrogen bonds: A:H.8
PLM.8: 2 residues within 4Å:- Chain B: V.18, L.91
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:V.18, B:L.91
PLM.9: 3 residues within 4Å:- Chain B: L.21, Y.28, Q.102
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:L.21, B:Y.28
PLM.10: 6 residues within 4Å:- Chain B: L.71, W.75
- Chain C: W.75, I.79
- Ligands: PLM.5, PLM.6
5 PLIP interactions:3 interactions with chain B, 2 interactions with chain C- Hydrophobic interactions: B:L.71, B:W.75, B:W.75, C:W.75, C:I.79
PLM.12: 1 residues within 4Å:- Chain C: L.91
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:L.91
PLM.13: 4 residues within 4Å:- Chain C: R.120, W.123
- Ligands: JUQ.11, PLM.14
No protein-ligand interaction detected (PLIP)PLM.14: 3 residues within 4Å:- Chain C: W.123
- Ligands: PLM.13, PLM.15
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:W.123
PLM.15: 4 residues within 4Å:- Chain C: W.123, L.124, A.127
- Ligands: PLM.14
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:L.124, C:A.127
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Munck Af Rosenschold, M. et al., Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma. J.Med.Chem. (2019)
- Release Date
- 2019-08-28
- Peptides
- Leukotriene C4 synthase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
EC
F - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x JUQ: (1~{S},2~{S})-2-[5-[cyclopropylmethyl(naphthalen-1-yl)amino]-4-methoxy-pyrimidin-2-yl]carbonylcyclopropane-1-carboxylic acid(Non-covalent)
- 1 x NI: NICKEL (II) ION(Non-covalent)
- 11 x PLM: PALMITIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Munck Af Rosenschold, M. et al., Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma. J.Med.Chem. (2019)
- Release Date
- 2019-08-28
- Peptides
- Leukotriene C4 synthase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
EC
F - Membrane
-
We predict this structure to be a membrane protein.